Generate a tailored SOP for Dr. Lq Chow. Improve your application with a focused, well-structured draft.
LQ Chow is a prominent figure in the field of oncology and immunotherapy, contributing significantly to the understanding of biomarkers predictive of response to treatments such as pembrolizumab in patients with head and neck cancer. Chow has been involved in various clinical trials and studies focusing on advanced solid tumors and has published extensively in high-impact journals. His research often emphasizes the intersection of tumor biology and treatment response, as well as the innovative use of liquid biopsy techniques to assess circulating tumor cells. Chow's work seeks to enhance the predictability and efficacy of cancer treatments, paving the way for personalized medicine approaches in oncology.